ATE439123T1 - Verwendung von emulsionen zur intra- und periocularen injection - Google Patents

Verwendung von emulsionen zur intra- und periocularen injection

Info

Publication number
ATE439123T1
ATE439123T1 AT04291684T AT04291684T ATE439123T1 AT E439123 T1 ATE439123 T1 AT E439123T1 AT 04291684 T AT04291684 T AT 04291684T AT 04291684 T AT04291684 T AT 04291684T AT E439123 T1 ATE439123 T1 AT E439123T1
Authority
AT
Austria
Prior art keywords
intra
emulsions
periocular injection
periocular
injection
Prior art date
Application number
AT04291684T
Other languages
English (en)
Inventor
Laura Rabinovich-Guilatt
Kozak Yvonne De
Catherine Dubernet
Gregory Lambert
Simon Benita
Patrick Couvreur
Francine Behar-Cohen
Original Assignee
Novagali Pharma Sa
Centre Nat Rech Scient
Inst Nat Sante Rech Med
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novagali Pharma Sa, Centre Nat Rech Scient, Inst Nat Sante Rech Med, Yissum Res Dev Co filed Critical Novagali Pharma Sa
Application granted granted Critical
Publication of ATE439123T1 publication Critical patent/ATE439123T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Enzymes And Modification Thereof (AREA)
AT04291684T 2004-07-02 2004-07-02 Verwendung von emulsionen zur intra- und periocularen injection ATE439123T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04291684A EP1611879B1 (de) 2004-07-02 2004-07-02 Verwendung von Emulsionen zur intra- und periocularen Injection

Publications (1)

Publication Number Publication Date
ATE439123T1 true ATE439123T1 (de) 2009-08-15

Family

ID=34931219

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04291684T ATE439123T1 (de) 2004-07-02 2004-07-02 Verwendung von emulsionen zur intra- und periocularen injection

Country Status (4)

Country Link
US (1) US20060002963A1 (de)
EP (1) EP1611879B1 (de)
AT (1) ATE439123T1 (de)
DE (1) DE602004022523D1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1827373B1 (de) 2004-11-09 2008-12-03 Novagali Pharma SA Prostaglandine enthaltende ophthalmische emulsionen
ES2314354T3 (es) 2004-11-09 2009-03-16 Novagali Pharma S.A. Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo.
PT2471530T (pt) 2005-06-01 2017-04-19 Edison Pharmaceuticals Inc Produtos terapêuticos com atividade redox para o tratamento de doenças mitocondriais e de outras condições e modulação de biomarcadores energéticos
AU2006311577B2 (en) 2005-11-09 2013-02-07 Zalicus Inc. Methods, compositions, and kits for the treatment of medical conditions
EP1986636B1 (de) 2006-02-22 2013-04-24 Edison Pharmaceuticals, Inc. Phenol- und 1,4-benzochinon-derivate zur verwendung in der behandlung von erkrankungen der mitochondrien
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
CN100435843C (zh) * 2006-04-21 2008-11-26 北京国丹药物技术开发有限公司 一种胸腺五肽与干扰素的组合物
SI1864668T1 (sl) * 2006-06-01 2013-04-30 Novagali Pharma S.A. Uporaba predzdravil za okularno intravitrealno dajanje
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
CN101130058B (zh) * 2006-08-23 2011-10-05 华北制药集团新药研究开发有限责任公司 一种环孢菌素a眼用乳剂及其制备方法
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
MX2010012080A (es) * 2008-05-05 2011-04-11 Univ Winthrop Hospital Metodo para mejorar el perfil de riesgo cardiovascular de los inhibidores de cox.
US8900627B2 (en) 2008-06-06 2014-12-02 Mirna Therapeutics, Inc. Compositions for the in vivo delivery of RNAi agents
US8314153B2 (en) 2008-09-10 2012-11-20 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
CN102395401B (zh) 2009-02-12 2015-08-19 因赛普特有限责任公司 经由水凝胶塞的药物递送
PL2424495T3 (pl) 2009-04-28 2018-06-29 Bioelectron Technology Corporation Leczenie dziedzicznej neuropatii nerwów wzrokowych lebera i dominującego zaniku nerwu wzrokowego chinonami tokotrienolu
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) * 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
CA2778181C (en) 2009-10-26 2024-05-28 Thomas Julius Borody Therapy for enteric infections
TW201138782A (en) * 2010-04-26 2011-11-16 Besins Healthcare Lu Sarl Low-oil pharmaceutical emulsion compositions comprising progestogen
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
WO2012138003A1 (ko) * 2011-04-08 2012-10-11 경북대학교 산학협력단 탈황산화된 헤파린-담즙산 유도체의 염증성 질환의 예방 및 치료 용도
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
CN109200013A (zh) 2011-12-05 2019-01-15 因赛普特有限责任公司 医用有机凝胶方法和组合物
HUE053669T2 (hu) 2012-12-05 2021-07-28 Novartis Ag Készítmények és eljárások EPO-t célzó antitestekre
RU2539161C2 (ru) * 2012-12-17 2015-01-10 Танзиля Сыонгалиевна Корнилова Способ лечения герпесвирусного поражения внутренних оболочек глаза
JP7097181B2 (ja) 2014-07-30 2022-07-07 マサチューセッツ アイ アンド イヤー インファーマリー 増殖性硝子体網膜症用メトトレキサート
CN107922975B (zh) 2015-08-12 2022-06-28 诺华股份有限公司 治疗眼科病症的方法
WO2017106803A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
AU2017312499B2 (en) 2016-08-19 2023-02-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration
WO2018033792A2 (en) 2016-08-19 2018-02-22 Orasis Pharmaceuticals Ltd. Ophthalmic pharmaceutical compositions and uses relating thereto
FR3057774B1 (fr) * 2016-10-21 2025-11-07 Museum Nat Dhistoire Naturelle Derives de la purine pour leur utilisation dans le traitement ou la prevention de maladies dues a une mutation non-sens
CN106963725A (zh) * 2017-04-19 2017-07-21 赵艳霞 一种地塞米松纳米凝胶及其制备方法
CN113648421A (zh) * 2021-08-19 2021-11-16 中山大学中山眼科中心 磺酰脲类药物在制备治疗葡萄膜炎的药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098443A (en) * 1989-03-23 1992-03-24 University Of Miami Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
IL98747A0 (en) * 1991-07-05 1992-07-15 Yissum Res Dev Co Ophthalmic compositions
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
AU680813B2 (en) * 1992-08-28 1997-08-14 Pharmos Corporation Submicron emulsions as ocular drug delivery vehicles
WO1995003009A1 (en) * 1993-07-22 1995-02-02 Oculex Pharmaceuticals, Inc. Method of treatment of macular degeneration
WO1995003807A1 (en) * 1993-07-27 1995-02-09 The University Of Sydney Treatment of age-related macular degeneration
AU9281698A (en) * 1997-10-01 1999-04-23 Wakamoto Pharmaceutical Co., Ltd. O/w emulsion compositions
DE10036871A1 (de) * 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
AU2002214233A1 (en) * 2001-11-01 2003-07-09 Novagali Pharma Sa Method and composition for dry eye treatment

Also Published As

Publication number Publication date
DE602004022523D1 (de) 2009-09-24
US20060002963A1 (en) 2006-01-05
EP1611879A1 (de) 2006-01-04
EP1611879B1 (de) 2009-08-12

Similar Documents

Publication Publication Date Title
ATE439123T1 (de) Verwendung von emulsionen zur intra- und periocularen injection
ATE498395T1 (de) Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
BRPI0415858A (pt) compostos de medicamentos terapêuticos modificados por tocoferol
ATE413162T1 (de) Pharmazeutische zusammensetzungen zur sicheren verabreichung von bei der behandlung von drogenabhängigkeit verwendeten arzneimitteln
ATE401874T1 (de) Verabreichung von capsaicinoiden
ATE555777T1 (de) Pharmazeutische zusammensetzung
ATE513562T1 (de) Nicht-spezifische immunstimulierende mittel
CY1118179T1 (el) Φαρμακευτικη συνθεση
EA200401252A1 (ru) Микрочастицы лекарственных веществ
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
BRPI0518460A2 (pt) mÉtodo para tratar emergÊncia alÉrgica em um paciente, dispositivo de distribuiÇço de droga contendo uma soluÇço de epinefrina, e, kit para tratar uma emergÊncia alÉrgia'
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
MXPA05006670A (es) Administracion de capsaicinoides.
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
CY1109070T1 (el) Διαδερμικη μορφη δοσολογιας περιλαμβανουσα ενα δραστικο παραγοντα και ενα αλας και μια μορφη ελευθερης βασεως ενος ανταγωνιστη
BRPI0519195A2 (pt) composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
WO2008117268A3 (en) A drug delivery device for providing local analgesia, local anesthesia or nerve blockade
ATE539747T1 (de) Verfahren und medikamente zur verabreichung von ibuprofen
SE0301663D0 (sv) Analysmetod för infusionsläkemedel
ATE434431T1 (de) Pharmazeutische formulierungen mit kurzketten- sphingolipiden und ihre verwendung
CY1108413T1 (el) Ενεσιμη φαρμακευτικη συνθεση που περιλαμβανει αιθανολη για την αγωγη των δισκοπαθειων
CR9200A (es) Uso de un agonista 5-ht6 para el tratamiento y la prevencion de trastornos neurodegenerativos
BRPI0508596A (pt) combinação compreendendo ligante alfa-2-delta
EA200500764A1 (ru) Фармацевтические композиции и лекарственные формы для трансбуккальной и сублингвальной доставки тизанидина и способы введения тизанидина сублингвально или трансбуккально
DK1617827T3 (da) Farmaceutisk sammensætning i form af en hydrogel til den transdermale administration af aktivstoffer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties